Boston Clinical Trials

Boston Clinical Trials is a private, revenue-generating clinical research organization (CRO) and site management organization (SMO) based in Roslindale, Massachusetts. Founded in 2008, it has conducted over 300 studies across more than 10 therapeutic areas, primarily focusing on central nervous system disorders, migraines, and other medical specialties. The company's business model is service-based, generating revenue from pharmaceutical and biotech sponsors for patient recruitment, trial execution, and site management. It differentiates itself through patient-centric services like compensation, evening appointments, and a convenient location.

Operational platform for clinical trial execution, including patient recruitment, site management, and potential integration of digital health tools for data capture and patient engagement. Not a proprietary therapeutic or diagnostic platform.

BCT competes with large global CROs, academic research centers (e.g., Massachusetts General Hospital, Brigham and Women's Hospital), and other independent dedicated research sites in the Northeast. Differentiation is based on patient-centric services, therapeutic area expertise (especially in CNS), and operational efficiency in a high-cost, talent-rich market.